Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and…
Young Minds Explore Creativity, Teamwork, and Healthy Habits at Manipal Hospital Yelahanka’s Children’s Day Event
BENGALURU, India, Nov. 26, 2025 /PRNewswire/ -- 'Healthy childhood is the foundation…
Apollo Hospitals rolls out its third facility in Maharashtra with a 400-bed quaternary care facility in Pune
PUNE, India, Nov. 24, 2025 /PRNewswire/ -- Apollo Hospitals, Asia's pioneering integrated healthcare…
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
Antibody levels remained well above baseline across all six serotypes and age…
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference
Kuros Biosciences to present at the Piper Sandler 37th Annual Healthcare Conference…
Indian MedTech Company Makes a Global Mark at PCR London Valves 2025
Presents One-Year Outcomes from the LANDMARK Randomized Controlled TrialVAPI, India, Nov. 25,…
The Volpi Rosse Menarini: The ‘Fantastic Ten’ are ready for the 2025 – 2026 Season
Italian wheelchair basketball team, sponsored by Menarini, was presented to the press…
Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS
Positive results from ianalumab pivotal Phase III trial in ITP patients previously…
Press Release: Sanofi and Regenerons Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the…
Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…